ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study

Clinical trial NCT04707235 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04707235
Sponsor: Theravia
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Sickle Cell Disease

Start date: 2020-08-21
Primary completion: 2025-08-21
Enrollment: 2093

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.